Harmonic Discovery
Multi-targeted therapeutics to treat complex diseases
New York, United States · Founded 2021 · $8.0M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2021
- Website
- harmonicdiscovery.com
- Total Funding
- $8.0M
- Last Round
- $8.0M SeedSep 2022
- Rounds
- 1
About
We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing proteins at once. By designing multi-specific drugs, we are able to create therapeutics that are more efficacious and safer than existing medicines.
Summary
Harmonic Discovery is a Biotech company based in New York, United States, founded in 2021. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Sep 2022. Investors include Innovation Endeavors and Boom Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2022
Investors
Similar Companies

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.